May 21, 2023 / 10:00PM GMT
Operator
Thank you for standing by, and welcome to the AFT Pharmaceuticals 2023 Full Year Results Analyst Briefing. (Operator Instructions) Finally, I would like to advise all participants that this call is being recorded. Your speakers today are Dr. Hartley Atkinson, CEO; and Malcolm Tubby, CFO.
I'd now like to welcome Dr. Hartley Atkinson, CEO, to begin the conference. Dr. Hartley, over to you.
Hartley Atkinson - AFT Pharmaceuticals Limited - Co-Founder, CEO, MD & Executive Director
Good. Thank you very much. Thank you, everyone, for joining the call today. So look, what I'd like to do is just to flick through the presentation. I'll do some of them, and Malcolm will do other parts of financial parts and in the end see if there's any questions.
So obviously, that's Page #1, which refers to this full financial year. Then Page #2 is a standard disclaimer, so if you can please read that and you go at your own time.
Page #3. Basically, what we're saying is we're pleased to be declaring and made a dividend, and we're pleased to also have yet
Full Year 2023 AFT Pharmaceuticals Ltd Earnings Call Transcript
Mar 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers